Replies to post #260 on Idenix Pharmaceuticals (IDIX)

[go seek]

No, the P3 trials are separate.
one for treatment naive wh/ is more advanced in clinical trials
and one for treatment refractory wh/ has been associated w/ higher or >200mg NM283 dosage.

The company would not delay the naive P3 trial for the sake of a refractory P3 trial.